FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13957811000001104: Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49993801000001118 Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78267801000001119 Supralip 160mg tablets (DE Pharmaceuticals) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is a Fenofibrate micronised 160mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is pack of Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has active ingredient Fenofibrate micronized false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has AMP Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Fenofibrate micronized true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start